| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.064 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |